Statements (28)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:public_company
|
gptkbp:category |
gptkb:S&P_500_companies
|
gptkbp:CEO |
gptkb:Albert_G._White_III
|
gptkbp:country |
gptkb:United_States
|
gptkbp:division |
gptkb:CooperVision
gptkb:CooperSurgical |
gptkbp:founded |
1958
|
gptkbp:foundedBy |
gptkb:Martin_H._Smith
|
gptkbp:headquartersLocation |
gptkb:San_Ramon,_California,_United_States
|
https://www.w3.org/2000/01/rdf-schema#label |
The Cooper Companies, Inc.
|
gptkbp:industry |
healthcare
medical devices |
gptkbp:ISIN |
US2166484016
|
gptkbp:marketCap |
over $20 billion (2023)
|
gptkbp:numberOfEmployees |
approximately 15,000
|
gptkbp:products |
contact lenses
fertility and women’s health products |
gptkbp:revenue |
$3.3 billion (2023)
|
gptkbp:SIC |
3845
|
gptkbp:stockExchange |
gptkb:NYSE
|
gptkbp:stockSymbol |
COO
|
gptkbp:subsidiary |
gptkb:CooperVision
gptkb:CooperSurgical |
gptkbp:tradedOn |
NYSE:COO
|
gptkbp:type |
public
|
gptkbp:website |
https://www.coopercos.com/
|
gptkbp:bfsParent |
gptkb:Cooper_Laboratories,_Inc.
|
gptkbp:bfsLayer |
8
|